Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[89Zr]Panitumumab-PET/MRI in Colon Cancer
NCT03764137Phase 2Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2019
- Primary completion
- Jan 2025
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of zirconium Zr 89 panitumumab in colon cancer, sponsored by University of Alabama at Birmingham. Planned start Mar 2019; status: withdrawn.
02
Drugs
zirconium Zr 89 panitumumab
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT03764137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03764137.